Our Company
What We Do
Mission Statement
Leadership Team
Our Clinical Trials
MultiVir Clinical Trials
Patients and Families
Medical Professionals
Technologies
Tumor Suppressor Immune Gene Therapy
Dendritic Cell Therapeutic Vaccines
Patients and Families
Welcome Patients and Families
MultiVir Clinical Trials
Medical Professionals
Medical Professionals
Investors and Media
Investors and Media
Search
Day: January 8, 2019
MultiVir Announces First Patient Treated in Human Clinical Trail of Tumor Suppressor p53 Immune Gene Therapy In Combination with immune Checkpoint Inhibitors
by Nick Puro